NCM
CELG

Neumann Capital Management’s Celgene Corp CELG Stock Holding History

Neumann Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,275
Closed -$623K – 73
2019
Q3 		$623K Hold
6,275
– – 0.39% 57
2019
Q2 		$580K Hold
6,275
– – 0.36% 57
2019
Q1 		$592K Sell
6,275
-300
-5% -$26.2K 0.38% 55
2018
Q4 		$421K Sell
6,575
-4,995
-43% -$369K 0.32% 60
2018
Q3 		$1.03M Sell
11,570
-185
-2% -$16.3K 0.61% 46
2018
Q2 		$934K Sell
11,755
-1,780
-13% -$148K 0.59% 48
2018
Q1 		$1.21M Buy
13,535
+2,640
+24% +$253K 0.77% 41
2017
Q4 		$1.14M Buy
10,895
+325
+3% +$36.7K 0.7% 45
2017
Q3 		$1.54M Buy
10,570
+8,770
+487% +$1.19M 0.95% 36
2017
Q2 		$234K Buy
+1,800
New +$221K 0.15% 71

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Neumann Capital Management's CELG Position: Q4 2019 in Review

Neumann Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,275 shares — an estimated $623K sold.

Neumann Capital Management first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $1.54M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Neumann Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Neumann Capital Management sold 6,275 Celgene Corp shares in Q4 2019, an estimated $623K.
  • Neumann Capital Management first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Neumann Capital Management's Celgene Corp position peaked at $1.54M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Neumann Capital Management's 13F filing for Q4 2019, filed 24 Jan 2020.